Effect of obesity on recombinant follicle-stimulating hormone absorption: subcutaneous versus intramuscular administration

Author： Steinkampf M.P. Hammond K.R. Nichols J.E. Slayden S.H.

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.80, Iss.1, 2003-07, pp. : 99-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A prospective, randomized study to assess the tolerance and efficacy of intramuscular and subcutaneous administration of recombinant follicle-stimulating hormone (Puregon)

By Out H.J. Reimitz P.E. Coelingh Bennink H.J.T.

Fertility and Sterility, Vol. 67, Iss. 2, 1997-02 ,pp. : 278-283

Elsevier

Access to resources Recommend Favorite

Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization

By Commenges-Ducos M. Piault S. Papaxanthos A. Ribes C. Dallay D. Commenges D.

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 1049-1054

Elsevier

Access to resources Recommend Favorite

Methodologic pitfalls in assessing the efficacy of recombinant follicle-stimulating hormone versus human menopausal gonadotropin in assisted reproduction

By Daya S.

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1100-1104

Elsevier

Access to resources Recommend Favorite

Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction

By Daya S.

Fertility and Sterility, Vol. 77, Iss. 4, 2002-04 ,pp. : 711-714

Elsevier

Access to resources Recommend Favorite

Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility

By Foresta C. Bettella A. Merico M. Garolla A. Ferlin A. Rossato M.

Fertility and Sterility, Vol. 77, Iss. 2, 2002-02 ,pp. : 238-244

Elsevier

Access to resources Recommend Favorite